These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 30266970)

  • 1. Imaging the evolution and pathophysiology of Alzheimer disease.
    Jagust W
    Nat Rev Neurosci; 2018 Nov; 19(11):687-700. PubMed ID: 30266970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
    Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
    J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease.
    Brier MR; Gordon B; Friedrichsen K; McCarthy J; Stern A; Christensen J; Owen C; Aldea P; Su Y; Hassenstab J; Cairns NJ; Holtzman DM; Fagan AM; Morris JC; Benzinger TL; Ances BM
    Sci Transl Med; 2016 May; 8(338):338ra66. PubMed ID: 27169802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease.
    Iaccarino L; Tammewar G; Ayakta N; Baker SL; Bejanin A; Boxer AL; Gorno-Tempini ML; Janabi M; Kramer JH; Lazaris A; Lockhart SN; Miller BL; Miller ZA; O'Neil JP; Ossenkoppele R; Rosen HJ; Schonhaut DR; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2018; 17():452-464. PubMed ID: 29159058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthreshold Amyloid Predicts Tau Deposition in Aging.
    Leal SL; Lockhart SN; Maass A; Bell RK; Jagust WJ
    J Neurosci; 2018 May; 38(19):4482-4489. PubMed ID: 29686045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau and β-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging.
    Marks SM; Lockhart SN; Baker SL; Jagust WJ
    J Neurosci; 2017 Mar; 37(12):3192-3201. PubMed ID: 28213439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
    Winer JR; Maass A; Pressman P; Stiver J; Schonhaut DR; Baker SL; Kramer J; Rabinovici GD; Jagust WJ
    JAMA Neurol; 2018 Feb; 75(2):227-235. PubMed ID: 29228071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.
    Wang L; Benzinger TL; Su Y; Christensen J; Friedrichsen K; Aldea P; McConathy J; Cairns NJ; Fagan AM; Morris JC; Ances BM
    JAMA Neurol; 2016 Sep; 73(9):1070-7. PubMed ID: 27454922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
    Bos I; Verhey FR; Ramakers IHGB; Jacobs HIL; Soininen H; Freund-Levi Y; Hampel H; Tsolaki M; Wallin ÅK; van Buchem MA; Oleksik A; Verbeek MM; Olde Rikkert M; van der Flier WM; Scheltens P; Aalten P; Visser PJ; Vos SJB
    Alzheimers Res Ther; 2017 Dec; 9(1):101. PubMed ID: 29284531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aβ-amyloid and Tau Imaging in Dementia.
    Villemagne VL; Doré V; Bourgeat P; Burnham SC; Laws S; Salvado O; Masters CL; Rowe CC
    Semin Nucl Med; 2017 Jan; 47(1):75-88. PubMed ID: 27987560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.
    Villemagne VL; Doré V; Burnham SC; Masters CL; Rowe CC
    Nat Rev Neurol; 2018 Apr; 14(4):225-236. PubMed ID: 29449700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Brain's Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer's Disease.
    Pandya S; Kuceyeski A; Raj A;
    J Alzheimers Dis; 2017; 55(4):1639-1657. PubMed ID: 27911289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex.
    Sepulcre J; Grothe MJ; Sabuncu M; Chhatwal J; Schultz AP; Hanseeuw B; El Fakhri G; Sperling R; Johnson KA
    JAMA Neurol; 2017 Jul; 74(7):813-820. PubMed ID: 28558094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicted sequence of cortical tau and amyloid-β deposition in Alzheimer disease spectrum.
    Cho H; Lee HS; Choi JY; Lee JH; Ryu YH; Lee MS; Lyoo CH
    Neurobiol Aging; 2018 Aug; 68():76-84. PubMed ID: 29751288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.
    Pettigrew C; Soldan A; Sloane K; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
    Neuroimage Clin; 2017; 16():439-446. PubMed ID: 28879085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-amyloid and tau drive early Alzheimer's disease decline while glucose hypometabolism drives late decline.
    Hammond TC; Xing X; Wang C; Ma D; Nho K; Crane PK; Elahi F; Ziegler DA; Liang G; Cheng Q; Yanckello LM; Jacobs N; Lin AL
    Commun Biol; 2020 Jul; 3(1):352. PubMed ID: 32632135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of Disease-modifying Therapy for Alzheimer's Disease].
    Akiyama H
    Brain Nerve; 2016 Apr; 68(4):463-72. PubMed ID: 27056864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.